The HLA-B*2709 subtype in a woman with early ankylosing spondylitis

Arthritis and Rheumatism

Volumn 56, Issue 8, 2007, Pages 2805-2807

  Olivieri, Ignazio ^a,b   D'Angelo, Salvatore ^a,b   Scarano, Enrico ^a   Santospirito, Vincenzo ^b   Padula, Angela ^a,b  

^a SAN CARLO HOSPITAL   (Italy)

^b MADONNA DELLE GRAZIE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; HLA B27 ANTIGEN; HLA B35 ANTIGEN; INFLIXIMAB; ANTIRHEUMATIC AGENT; HLA B 2709 ANTIGEN; HLA-B 2709 ANTIGEN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONTINUOUS INFUSION; FEMALE; HAPLOTYPE; HLA TYPING; HUMAN; LOW BACK PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SACROILIAC JOINT; GENETIC PREDISPOSITION; GENETICS; HISTOCOMPATIBILITY TEST; HOSPITALIZATION; PATHOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HISTOCOMPATIBILITY TESTING; HLA-B ANTIGENS; HUMANS; MAGNETIC RESONANCE IMAGING; PAIN MEASUREMENT; SACROILIAC JOINT; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

EID: 34547787072     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22821     Document Type: Article

References (17)

1. Reveille JD. The genetic basis of ankylosing spondylitis. Curr Opin Rheumatol 2006;18:332-41.
2. Nasution AR, Mardjuadi A, Kunmartini S, Suryadhana NG, Setyohadi B, Sudarsono D, et al. HLA-B27 subtypes positively and negatively associated with spondyloarthropathy. J Rheumatol 1997;24:1111-4.
3. D'Amato M, Fiorillo MT, Carcassi A, Mathieu A, Zuccarelli A, Bitti PP, et al. Relevance of residue 116 of HLA-B27 in determining susceptibility to ankylosing spondylitis. Eur J Immunol 1995;25:3199-201.
4. Hulsmeyer M, Fiorillo MT, Bettosini F, Sorrentino R, Saenger W, Ziegler A, et al. Dual, HLA-B27 subtype-dependent conformation of a self-peptide. J Exp Med 2004;199:271-81.
5. Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
6. Goodall JC, Ellis L, Hill Gaston JS. Spondylarthritis-associated and non-spondylarthritis-associated B27 subtypes differ in their dependence upon tapasin for surface expression and their incorporation into the peptide loading complex. Arthritis Rheum 2006;54:138-47.
7. Paladini F, Taccari E, Fiorillo MT, Cauli A, Passiu G, Mathieu A, et al. Distribution of HLA-B27 subtypes in Sardinia and continental Italy and their association with spondylarthropathies. Arthritis Rheum 2005;52:3319-21.
8. Olivieri I, Padula A, Ciancio G, Moro L, Durante E, Gaudiano C, et al. The HLA-B*2709 subtype in a patient with undifferentiated spondylarthritis [letter]. Ann Rheum Dis 2000;59:654-5.
9. Olivieri I, Ciancio G, Padula A, Gaudiano C, Masciandaro S, Moro L, et al. The HLA-B*2709 subtype confers susceptibility to spondylarthropathy. Arthritis Rheum 2002;46:553-4.
10. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calm A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
11. Calin A, Garrett S, Whitelock H, Kennedy LG, O'Hea J, Mallorie P, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5.
12. Rudwaleit M, Khan MA, Sieper J. The challenge of diagnosis and classification in early ankylosing spondylitis: do we need new criteria? Arthritis Rheum 2005;52:1000-8.
13. Braun J, Baraliakos X, Golder W, Brandt J, Rudwaleit M, Listing J, et al. Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: evaluation of a new scoring system. Arthritis Rheum 2003;48:1126-36.
14. Baraliakos X, Listing J, Rudwaleit M, Brandt J, Sieper J, Braun J, et al. Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumor necrosis factor α antibody infliximab. Ann Rheum Dis 2005;64:1462-6.
15. Olivieri I, Padula A, Pierro A, Favaro L, Oranges GS, Ferri S. Late onset undifferentiated seronegative spondylarthropathy. J Rheumatol 1995;22:899-903.
16. Sudarsono D, Hadi S, Mardjuadi A, Nasution AR, Dekker-Saeys AJ, Breur-Vriesendorp BS, et al. Evidence that HLA-B*2706 is not protective against spondyloarthopathy. J Rheumatol 1999;26:1534-6.
17. De Vlam K, Mielants H, Cuvelier C, De Keyser F, Veys EM, De Vos M. Spondyloarthropathy is underestimated in inflammatory bowel disease: prevalence and HLA association. J Rheumatol 2000;27:2860-5.